DIR fees

Controversy heats up over pharmacy benefit manager DIR feesPBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.
Report: Community Pharmacy Has Broadened Scope of Services
Report: Community Pharmacy Has Broadened Scope of ServicesA new NCPA report highlights the role of community pharmacies.
The Future of Independent Pharmacy
The Future of Independent PharmacyNCPA CEO B. Douglas Hoey, RPh, MBA, discusses the problems and opportunities facing independent pharmacies.
DIR Fees, Medical Marijuana Among Hot Topics at NCPA ConventionWhat you need to know about the upcoming NCPA convention.
Removing DIR Fees Could Save Billions
Removing DIR Fees Could Save BillionsA study commissioned by the NCPA shows the effect of DIR fees.
New Website Reveals DIR Fee Problems
New Website Reveals DIR Fee ProblemsNASP takes aim at DIR fees.
New DIR Fee Estimator Can Help Pharmacies Manage Cash FlowElevate Provider Network estimates DIR fees in advance
DIR Fees: What NCPA Wants from Part DIn a letter to the CMS, DIR fees take precedence
New Report: PBMs Push Drug Costs
New Report: PBMs Push Drug CostsAre PBMs responsible for higher drug prices or is something else to blame?
Reader Response